Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

year-over-year, gross margins up over 300 basis points year-over-year, and core OTC [1] contribution margin dollars up 40% year-over-year. Our core OTC business grew 18% year-over-year, in-line with ecommerce trends, but below our expectations due to increased marketing costs in paid search and portals."

"Throughout 2008, we expect to accelerate our full year top line revenue growth by: increasing sales in each one of our business segments, driving OTC sales by 20% year-over-year and increasing prestige beauty sales more than 40% year-over-year. In the first quarter of 2008, we are making targeted investments in a number of our profitability initiatives including pricing and sourcing to further expand margins. We will start to see the benefits of these investments in the second quarter and we expect to double full year adjusted EBITDA and to exit the year with gross margins above 26% and adjusted EBITDA margins between 5-6%," concluded Ms. Lepore.

GAAP net income for the fourth quarter of 2007 was $156,000, or $0.00 per share, compared to a net loss of $2.9 million, or $0.03 per share, for the fourth quarter of 2006. The fourth quarter in both 2007 and 2006 included $1.7 million in non-cash stock-based compensation expense. GAAP net loss for the fiscal year of 2007 was $9.0 million or $0.09 per share, compared to a net loss of $13.0 million, or $0.14 per share, for the fiscal year of 2006. The fiscal year losses include $8.8 million and $6.7 million, in non-cash stock- based compensation expense for 2007 and 2006, respectively.

Outlook for First Quarter and Fiscal Year 2008

For fiscal year 2008, the company is targeting net sales in the range of $498.0 million to $512.0 million, net income in the range of $(1.0) million to $3.0 million, and adjusted EBITDA in the range of $18.0 million to $22.0 million.

For the first quarter of 2008, the company is targeting net sales in the range of $118.0 million to $122.0 million, net loss in th
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...., Dec. 2 A number of recent publi...hood obesity, the health risks in,overweight chil...reals and,other foods kids consume. Yet one manu... natural, freeze-dried real fruit products that ar...provide most, if not all, of the daily fruit,serv...
(Date:12/2/2008)...hed Call to Action Highlights Need to Reduce Dispa...ational Efforts , , BETHESDA, Md., Dec. 2 ...tious Diseases, (NFID) S.T.O.P. (Share. Teach. O...ed of many of the nation,s leading medical and adv...ion to improve adolescent meningococcal vaccinatio...
(Date:12/2/2008)...ants can help keep driving safe, research shows ,...ivers talking on a cell phone are more distracted ... with a friend sitting next to them in the car, a ... process of joint attention, so when you have a pe...river, that person actually understands something ...
(Date:12/2/2008)...t Expands Leadership Team and Strengthens Commerci...wire/ -- BioNanomatrix, Inc., a developer of break...ics, personalized medicine and biomedical research... Ph.D., as vice president of business development....ess development experience with leading biotechnol...
Breaking Medicine News(10 mins):Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 2Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 3
...ould cut the risk of getting bowel cancer by more...ts do not recommend its continuous use due to poss...t tumors in the lower end of the gastro-intestinal...rs occur in the large intestine and 20 percent in ...
...ric name clopidogrel), the popular anti-blood-clot...ent recommended dose of Plavix to angioplasty pati... risk of heart attack and cardiac death by half. ...assistant professor of medicine at Virginia Common...
...essed over the housing together of two convicted p... Robbie Sebastian Wheeler, 43, and his boyfriend ...her in Hakea jail, in West Australia. The two men...ping a teenage boy and sexually molesting him for ...
... in children, according to a new study by a Housto...the survey studied the dietary intakes of 3,618 ch...t find a relationship between 100 percent juice co...among children," said Theresa Nicklas, a child nut...
Other Medicine News:Health News:Doubling Plavix Dose Recommended Before Angioplasty 2Health News:Outrage Against Gay PartnersInCrime Kept Together 2
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/25/2008)...ewswire-FirstCall/ -- CardioVascular,BioTherapeut...day that it has,dosed the first patient in North ...al trial to treat patients with severe coronary he...tment of CORonary heart Disease) trial will includ...ed doses in approximately 120,patients with sever...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
(Date:11/24/2008)...Cancer Awareness Month , , Oak Brook, Ill.,...Society for Gastrointestinal Endoscopy (ASGE) and ...p this November to raise awareness about pancreati... the resources that are available for them. , ... of cancer deaths in the U.S. In 2008, an estimate...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4Houston Heart Surgeon Elected Vice President of Guatemala 5534 1Houston Heart Surgeon Elected Vice President of Guatemala 5534 2Fragile X Foundations Sign Merger Agreement 5532 1Fragile X Foundations Sign Merger Agreement 5532 2Fragile X Foundations Sign Merger Agreement 5532 3Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 1Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 2
...d at the American College of,Cardiology,s Scientif...RNewswire-FirstCall/ -- CV,Therapeutics, Inc. anno...m the MERLIN TIMI-36 study of ranolazine shows the... patients on ranolazine.,The study did not meet th...the company,s special protocol assessment,agreemen...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model.
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Medium 23 mm. Overall length: 3.9 inches.
One end with needle point and other end with medium taper. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches.
Medicine Products: